Pharmacy Question for the Week of September 18, 2017

Question:

What code and modifier should be used to report an injection of the biosimilar drug infliximab?

Answer:

Q5102 (effective April 5, 2016) can be reported with either the existing modifier ZB (Pfizer/Hospira, effective April 1, 2016) or new modifier ZC (Merck/Samsung Bioepis, effective July 1, 2017).

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

CPT® copyright 2023 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’  is just $99 for a limited time! Use code WorldHealth24 at checkout.

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →